MAZE - CIK 0001842295
Maze Therapeutics, Inc. (MAZE) reported revenue of $167.50M for fiscal year 2024, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2024 | $167.50M | - |
Maze Therapeutics, Inc. (MAZE) reported revenue of $167.50M for fiscal year 2024, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.